Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.

Zhang L, Jiao M, Hou Y, Jie Y, Mo S, Chen W, Xue Q, Qiao Y

Open source

DOI
10.1016/j.rmcr.2026.102521
Published
2026
Container
Respiratory medicine case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmcr.2026.102521,
  title = {Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.},
  author = {Zhang L and Jiao M and Hou Y and Jie Y and Mo S and Chen W and Xue Q and Qiao Y},
  year = {2026},
  journal = {Respiratory medicine case reports},
  doi = {10.1016/j.rmcr.2026.102521},
  url = {https://doi.org/10.1016/j.rmcr.2026.102521}
}

RIS

TY  - JOUR
TI  - Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.
AU  - Zhang L
AU  - Jiao M
AU  - Hou Y
AU  - Jie Y
AU  - Mo S
AU  - Chen W
AU  - Xue Q
AU  - Qiao Y
PY  - 2026
JO  - Respiratory medicine case reports
DO  - 10.1016/j.rmcr.2026.102521
UR  - https://doi.org/10.1016/j.rmcr.2026.102521
ER  - 

APA

L, Z., M, J., Y, H., Y, J., S, M., W, C., Q, X., & Y, Q. (2026). Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.. Respiratory medicine case reports. https://doi.org/10.1016/j.rmcr.2026.102521

Source records